Utility of the Midbrain Tegmentum Diameter in the Differential Diagnosis of Progressive Supranuclear Palsy from Idiopathic Parkinson's Disease
- PMID: 26174787
- PMCID: PMC4507382
- DOI: 10.3988/jcn.2015.11.3.268
Utility of the Midbrain Tegmentum Diameter in the Differential Diagnosis of Progressive Supranuclear Palsy from Idiopathic Parkinson's Disease
Abstract
Background and purpose: Various magnetic resonance (MR) measurements have been proposed to aid in differentiating between progressive supranuclear palsy (PSP) and idiopathic Parkinson's disease (IPD); however, these methods have not been compared directly. The aim of this study was to determine which measurement method exhibits the highest power to differentiate between PSP and IPD.
Methods: Brain MR images from 82 IPD and 29 PSP patients were analyzed retrospectively. T1-weighted 3D volumetric axial images, or sagittal images reconstructed from those axial images were examined. MR measurements included the length from the interpeduncular fossa to the center of the cerebral aqueduct at the mid-mammillary-body level, adjusted according to the anterior commissure-posterior commissure length (MB(Tegm)), the ratio of the midbrain area to the pons area (M/P ratio) as measured by both Oba's method (Oba M/P) and Cosottini's method (Cosottini M/P), and a modified MR parkinsonism index (mMRPI).
Results: Receiver operating characteristic (ROC) analysis indicated that the areas under the ROC curves (AUCs) exceeded 0.70, with a high intrarater reliability for all MR measurement methods. ROC analyses of four MR measurements yielded AUCs of 0.69-0.76. At the cutoff value with the highest Youden index, mMRPI had the highest sensitivity, while Oba M/P offered the highest specificity. A comparison of the ROC analyses revealed that MB(Tegm) was superior to mMRPI in differentiating PSP from IPD (p=0.049). There was no difference in discriminating power among Oba M/P, Cosottini M/P, and MB(Tegm).
Conclusions: Simple measurements of MB(Tegm) on axial MR images at the mid-mammillary-body level are comparable to measurements of the M/P ratio with regard to their ability to discriminate PSP from IPD.
Keywords: MRI; idiopathic Parkinson's disease; neuroimaging; progressive supranuclear palsy.
Conflict of interest statement
Figures


Similar articles
-
MRI measurements of brainstem structures in patients with vascular parkinsonism, progressive supranuclear palsy, and Parkinson's disease.Neurol Sci. 2017 Apr;38(4):627-633. doi: 10.1007/s10072-017-2812-1. Epub 2017 Jan 11. Neurol Sci. 2017. PMID: 28078564
-
Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.Neuroimage Clin. 2016 May 30;11:736-742. doi: 10.1016/j.nicl.2016.05.016. eCollection 2016. Neuroimage Clin. 2016. PMID: 27330973 Free PMC article.
-
MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy.Neurol Res. 2019 Feb;41(2):110-117. doi: 10.1080/01616412.2018.1541115. Epub 2018 Oct 30. Neurol Res. 2019. PMID: 30373485
-
Diagnostic validity of magnetic resonance parkinsonism index in differentiating patients with progressive supranuclear palsy from patients with Parkinson's disease.Parkinsonism Relat Disord. 2019 Sep;66:176-181. doi: 10.1016/j.parkreldis.2019.08.007. Epub 2019 Aug 10. Parkinsonism Relat Disord. 2019. PMID: 31420309
-
Diagnostic Performance of Putaminal Hypointensity on Susceptibility MRI in Distinguishing Parkinson Disease from Progressive Supranuclear Palsy: A Meta-Analysis.Mov Disord Clin Pract. 2022 Oct 19;10(2):168-174. doi: 10.1002/mdc3.13573. eCollection 2023 Feb. Mov Disord Clin Pract. 2022. PMID: 36825057 Free PMC article. Review.
Cited by
-
MRI measurements of brainstem structures in patients with vascular parkinsonism, progressive supranuclear palsy, and Parkinson's disease.Neurol Sci. 2017 Apr;38(4):627-633. doi: 10.1007/s10072-017-2812-1. Epub 2017 Jan 11. Neurol Sci. 2017. PMID: 28078564
-
Planimetric and Volumetric Brainstem MRI Markers in Progressive Supranuclear Palsy, Multiple System Atrophy, and Corticobasal Syndrome. A Systematic Review and Meta-Analysis.Neurol Int. 2023 Dec 19;16(1):1-19. doi: 10.3390/neurolint16010001. Neurol Int. 2023. PMID: 38392951 Free PMC article. Review.
-
Higher prevalence of idiopathic normal pressure hydrocephalus-like MRI features in progressive supranuclear palsy: An imaging reminder of atypical parkinsonism.Brain Behav. 2023 Feb;13(2):e2884. doi: 10.1002/brb3.2884. Epub 2023 Jan 12. Brain Behav. 2023. PMID: 36635882 Free PMC article.
-
Conventional Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Disorders: A Meta-Analysis.Mov Disord Clin Pract. 2020 Sep 14;8(2):217-223. doi: 10.1002/mdc3.13070. eCollection 2021 Feb. Mov Disord Clin Pract. 2020. PMID: 33553491 Free PMC article.
-
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?Mov Disord. 2017 Jul;32(7):955-971. doi: 10.1002/mds.27038. Epub 2017 May 13. Mov Disord. 2017. PMID: 28500751 Free PMC article. Review.
References
-
- Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord. 2003;18:467–486. - PubMed
-
- Warmuth-Metz M, Naumann M, Csoti I, Solymosi L. Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol. 2001;58:1076–1079. - PubMed
-
- Righini A, Antonini A, Ferrarini M, de Notaris R, Canesi M, Triulzi F, et al. Thin section MR study of the basal ganglia in the differential diagnosis between striatonigral degeneration and Parkinson disease. J Comput Assist Tomogr. 2002;26:266–271. - PubMed
-
- Kato N, Arai K, Hattori T. Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci. 2003;210:57–60. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous